University Hospitals Beachwood Medical Center
25501 Chagrin Boulevard, Beachwood, OH · University Hospitals · · NPI 1841789427
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Injection, siltuximab HCPCS J2860 | $23,535.37 | $31,380.49 | $82.16 – $7,060.60 | 37 |
| Injection(s) tendon sheath/ligament aponeurosis single (both sides) CPT 20550 | $255.00 | $340.00 | $136.00 – $735.50 | 37 |
| Injection(s) trigger point(s) single/multiple 1 or 2 muscle(s) CPT 20552 | $1,078.50 | $1,438.00 | $290.40 – $1,294.20 | 37 |
| Injection(s) trigger point(s) single/multiple >= 3 muscle(s) CPT 20553 | $656.25 | $875.00 | $290.40 – $787.50 | 37 |
| Injection therapeutic/prophylactic/diagnostic each addl sequential IV push same substance/drug CPT 96376 | $573.00 | $764.00 | $305.60 – $687.60 | 24 |
| Injection treatment of eye CPT 66020 | not published | not published | $1,441.44 – $5,529.89 | 20 |
| Injection treatment of eye CPT 66030 | not published | not published | $1,441.44 – $5,529.89 | 20 |
| Injection treatment of nerve CPT 64605 | $2,238.00 | $2,984.00 | $900.00 – $4,679.02 | 37 |
| Injection treatment of nerve CPT 64610 | not published | not published | $1,441.44 – $4,679.02 | 20 |
| Injection treatment of nerve CPT 64681 | $2,708.25 | $3,611.00 | $836.78 – $3,249.90 | 37 |
| Injection treatment of nose CPT 30200 | not published | not published | $510.25 – $1,292.32 | 19 |
| Inject sacroiliac joint CPT 27096 | $492.00 | $656.00 | $77.90 – $590.40 | 37 |
| Inject/treat eye socket CPT 67500 | not published | not published | $300.29 – $760.54 | 19 |
| Inject/treat eye socket CPT 67505 | not published | not published | $300.29 – $760.54 | 19 |
| Inject/treat eye socket CPT 67515 | not published | not published | $300.29 – $760.54 | 19 |
| Inj, eculizumab-aagh, 2 mg HCPCS Q5151 | not published | not published | $31.93 – $57.47 | 19 |
| Inj, eculizumab-aeeb, 2 mg HCPCS Q5152 | not published | not published | $41.79 – $75.22 | 19 |
| Inj efgart-alfa 2mg hya-qvfc HCPCS J9334 | not published | not published | $34.33 – $61.79 | 19 |
| Inj eflapegrastim-xnst 0.1mg HCPCS J1449 | not published | not published | $38.96 – $70.12 | 19 |
| Inj., emapalumab-lzsg, 1 mg HCPCS J9210 | not published | not published | $384.14 – $691.44 | 19 |
| Inj., emicizumab-kxwh 0.5 mg HCPCS J7170 | $58,842.17 | $78,456.22 | $26.26 – $14,122.13 | 37 |
| Inj epidural sgl cerv-thor without img CPT 62320 | $2,184.75 | $2,913.00 | $667.82 – $2,621.70 | 37 |
| Inj epidural sgl lumb-sacral without img CPT 62322 | $1,623.75 | $2,165.00 | $836.78 – $2,119.32 | 37 |
| Inj., eravacycline, 1 mg HCPCS J0122 | $248.03 | $330.70 | $0.61 – $297.63 | 37 |
| Inj, erzofri, 1 mg HCPCS J2428 | not published | not published | $14.49 – $26.08 | 19 |
| Inj, etelcalcetide, 0.1 mg HCPCS J0606 | $1,404.58 | $1,872.77 | $1.11 – $421.38 | 37 |
| Inj, eteplirsen, 10 mg HCPCS J1428 | not published | not published | $167.51 – $301.52 | 19 |
| Inj, evinacumab-dgnb, 5mg HCPCS J1305 | not published | not published | $197.63 – $355.74 | 19 |
| Inj., evomela, 1 mg HCPCS J9246 | not published | not published | $19.43 – $34.97 | 19 |
| Inj, exagamglogene autotem HCPCS J3392 | not published | not published | $2,332,000.00 – $4,197,600.00 | 19 |
| Inj, factor x, (human), 1iu HCPCS J7175 | $33.28 | $44.37 | $4.70 – $39.93 | 37 |
| Inj, faricimab-svoa, 0.1mg HCPCS J2777 | not published | not published | $32.87 – $59.16 | 19 |
| Inj. fe derisomaltose 10 mg HCPCS J1437 | not published | not published | $21.93 – $39.47 | 19 |
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $140.71 – $253.28 | 19 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.24 – $2.23 | 19 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $2.55 – $4.58 | 19 |
| Inj for ext venography CPT 36005 | $1,434.75 | $1,913.00 | $106.88 – $1,721.70 | 37 |
| Inj for mammo ductogram CPT 19030 | $150.00 | $200.00 | $70.93 – $270.48 | 37 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $0.04 – $0.06 | 19 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $524.18 – $943.52 | 19 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | $2,588.63 | $3,451.50 | $900.00 – $3,106.35 | 24 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | $1,713.99 | $2,285.31 | $12.80 – $2,056.78 | 37 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $41.67 – $75.01 | 19 |
| Inj givosiran 0.5 mg HCPCS J0223 | $162,298.07 | $216,397.42 | $57.10 – $194,757.68 | 37 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,840.68 – $5,113.22 | 19 |
| Inj glycopyrrolate, glyrx-pf HCPCS J1597 | $8.22 | $10.96 | $4.38 – $9.86 | 24 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $3.88 – $6.98 | 19 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $67.81 – $122.06 | 19 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,691,450.00 – $6,644,610.00 | 19 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | $17,286.71 | $23,048.94 | $28.28 – $20,744.05 | 37 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $37.87 – $68.16 | 19 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $56.02 – $100.83 | 19 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | $1,110.00 | $1,480.00 | $21.17 – $17,103.00 | 37 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | $2,622.00 | $3,496.00 | $23.32 – $17,103.00 | 37 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | $1,192.50 | $1,590.00 | $24.75 – $17,103.00 | 37 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | $1,239.00 | $1,652.00 | $12.22 – $17,103.00 | 37 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | $5,894.25 | $7,859.00 | $11.73 – $17,103.00 | 37 |
| Inj human fibrinogen con nos HCPCS J7178 | $4,326.08 | $5,768.10 | $0.72 – $5,191.29 | 37 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $5.44 – $9.80 | 19 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $77.68 – $139.82 | 19 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | $1,083.72 | $1,444.95 | $577.98 – $1,300.46 | 24 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $79.44 – $142.99 | 19 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | $172,856.28 | $230,475.04 | $233.90 – $207,427.54 | 37 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | $2,233.50 | $2,978.00 | $836.78 – $2,680.20 | 37 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | $206.25 | $275.00 | $110.00 – $480.75 | 37 |
| Inj intralesional > 7 lsns CPT 11901 | $222.75 | $297.00 | $118.80 – $480.75 | 37 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $12.95 – $23.31 | 19 |
| Inj ivig privigen 500 mg HCPCS J1459 | $4,194.45 | $5,592.60 | $23.38 – $5,033.34 | 37 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.97 – $3.55 | 19 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.66 – $4.78 | 19 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.56 – $2.82 | 19 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $86.85 – $156.32 | 19 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $32.19 – $57.94 | 19 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.34 – $2.40 | 19 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $22.30 – $40.14 | 19 |
| Inj levocarnitine per 1 gm HCPCS J1955 | $122.28 | $163.04 | $41.14 – $92.56 | 24 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | $76.51 | $102.01 | $40.80 – $91.81 | 24 |
| Inj, levothyroxine, freskabi HCPCS J0651 | $244.63 | $326.17 | $3.28 – $293.55 | 37 |
| Inj, lidocaine w epinephrine HCPCS J2004 | $37.17 | $49.55 | $2.33 – $5.24 | 24 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,245,381.39 – $5,841,686.50 | 19 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $327.72 – $589.89 | 19 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $23.39 – $42.11 | 19 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,070.09 – $5,526.16 | 19 |
| Inj lwr xtr fscl pln blk uni w/wo image CPT 64473 | $1,471.50 | $1,962.00 | $59.98 – $1,765.80 | 37 |
| Inj marstacim-hncq, 0.5 mg HCPCS J7172 | not published | not published | $50.19 – $90.34 | 19 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | $1,713.99 | $2,285.31 | $56.96 – $240.67 | 37 |
| Inj, melphalan (apotex) 1 mg HCPCS J9249 | not published | not published | $64.78 – $116.60 | 19 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $795.00 – $1,431.00 | 19 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | $28.41 | $37.87 | $11.18 – $25.16 | 24 |
| Inj., meropenem, vaborbactam HCPCS J2186 | $759.87 | $1,013.15 | $1.03 – $911.84 | 37 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $42.09 – $75.77 | 19 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | $17,682.90 | $23,577.19 | $119.64 – $21,219.47 | 37 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $26.48 – $47.66 | 19 |
| Inj multihance HCPCS A9577 | $166.47 | $221.95 | $22.63 – $50.92 | 24 |
| Inj. mycophenolate mofetil HCPCS J7519 | $387.27 | $516.36 | $44.02 – $99.04 | 24 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | $96,378.67 | $128,504.89 | $323.84 – $115,654.40 | 37 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | $522.75 | $697.00 | $278.80 – $1,670.82 | 37 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $2.17 – $3.90 | 19 |
| Inj nivolumab 2 mg hyaluron HCPCS J9289 | not published | not published | $27.73 – $49.91 | 19 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $94.60 – $170.28 | 19 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.